Literature DB >> 33426174

Symptom-Triggered Attention to Self as a Possible Trigger of Functional Comorbidity.

Anne-Catherine M L Huys1, Kailash P Bhatia1, Patrick Haggard2, Mark J Edwards3.   

Abstract

Entities:  

Keywords:  functional overlay, functional movement disorders, movement disorders, attention, movement specific reinvestment scale

Year:  2020        PMID： 33426174      PMCID： PMC7781079          DOI： 10.1002/mdc3.13120

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  4 in total

1.  How changing the focus of attention affects performance, kinematics, and electromyography in dart throwing.

Authors:  Keith R Lohse; David E Sherwood; Alice F Healy
Journal:  Hum Mov Sci       Date:  2010-06-11       Impact factor: 2.161

2.  Increased movement accuracy and reduced EMG activity as the result of adopting an external focus of attention.

Authors:  Tiffany Zachry; Gabriele Wulf; John Mercer; Neil Bezodis
Journal:  Brain Res Bull       Date:  2005-10-30       Impact factor: 4.077

3.  Psychogenic dyskinesias in patients with organic movement disorders.

Authors:  R Ranawaya; D Riley; A Lang
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

4.  Which neurological diseases are most likely to be associated with "symptoms unexplained by organic disease".

Authors:  J Stone; A Carson; R Duncan; R Roberts; R Coleman; C Warlow; G Murray; A Pelosi; J Cavanagh; K Matthews; R Goldbeck; M Sharpe
Journal:  J Neurol       Date:  2011-06-16       Impact factor: 4.849
  4 in total
  2 in total

1.  No exaggerated tremor severity perception in functional tremor.

Authors:  Anne-Catherine M L Huys; Patrick Haggard; Kailash P Bhatia; Mark J Edwards
Journal:  J Neurol       Date:  2022-07-20       Impact factor: 6.682

2.  Misdirected attentional focus in functional tremor.

Authors:  Anne-Catherine M L Huys; Patrick Haggard; Kailash P Bhatia; Mark J Edwards
Journal:  Brain       Date:  2021-12-16       Impact factor: 13.501
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.